Attomarker is short-listed as one of the top four global contenders for the £10 million Longitude Prize, for the best invention designed to combat antimicrobial resistance.
Attomarker is ranked among the top five companies globally for fighting antimicrobial resistance by The World Health Organisation / FINDdx.
Attomarker is currently touring India & China in the Science Museum’s Superbugs exhibition.
And being exhibited in their brand-new £24 million ‘Medicine: Wellcome Galleries’ in Kensington.
Johnson & Johnson
Identified as a Top Three biomarker@home by Johnson & Johnson.
obn Awards 2019
Winner of the OBN Life Sciences Industry ‘One to Watch’ award, 2019.